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Recently, Jannick Theobald and Xinlai Cheng from Heidelberg University published a methods\' paper how to monitor cytochrome P450 (CYP) activities in living hepatocytes (Theobald et al., 2017\[[@R15]\]). For this purpose, the authors used substrates that are metabolized by CYP enzymes thereby forming highly fluorescent leaving groups that were quantified by a plate reader. This technique allows repeated real-time measurements of cultivated hepatocytes over extincted time periods (Theobald et al., 2017\[[@R15]\]). The monitoring technique was validated by the use of CYP inducers and was applied to characterize differentiating HepaRG cells. The authors conclude that the fluorescence-based assay can easily be used as a tool to characterize hepatocyte *in vitro* systems.

Hepatotoxicity still represents a major challenge in drug development (Leist et al., 2017\[[@R8]\]; Schenk et al., 2017\[[@R12]\]; Reif et al., 2017\[[@R11]\]; Jansen et al., 2017\[[@R6]\]; Crespo Yanguas et al., 2016\[[@R3]\]; Stöber, 2015\[[@R13]\], 2016\[[@R14]\]; Yanguas et al., 2016\[[@R19]\]; Braeuning and Schwarz, 2016\[[@R2]\]).

Currently, much effort is invested to develop improved hepatocyte *in vitro* systems (Godoy et al., 2013\[[@R5]\]; Ramboer et al., 2015\[[@R10]\]; Verhulst et al., 2015\[[@R18]\]; Pfeiffer et al., 2015\[[@R9]\]; Kim et al., 2015\[[@R7]\]) and *in silico* techniques (Ghallab et al., 2016\[[@R4]\]; Bartl et al., 2015\[[@R1]\]; Vartak et al., 2016\[[@R17]\]; Thiel et al., 2015\[[@R16]\]). The technique presented by Theobald and colleagues can easily be integrated into *in vitro* systems and should therefore facilitate characterization of cultivated hepatocytes.
